Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases
Author(s) -
QuynhNhu Nguyen,
Stephen G. Chun,
Edward Chow,
Ritsuko Komaki,
Zhongxing Liao,
Rensi Zacharia,
Bill K. Szeto,
James W. Welsh,
Stephen M. Hahn,
Clifton D. Fuller,
Bryan S. Moon,
Justin E. Bird,
Robert L. Satcher,
Patrick P. Lin,
Melenda Jeter,
Michael S. O’Reilly,
Valerae O. Lewis
Publication year - 2019
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2019.0192
Subject(s) - medicine , dose fractionation , radiation therapy , randomized controlled trial , clinical endpoint , surgery , nuclear medicine
Consensus is lacking as to the optimal radiotherapy dose and fractionation schedule for treating bone metastases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom